Formononetin triggers ferroptosis in triple-negative breast cancer cells by regulating the mTORC1/SREBP1/SCD1 pathway

IntroductionTriple-negative breast cancer (TNBC) is the most malignant type of breast cancer, and its prognosis is still the worst. It is necessary to constantly explore the pathogenesis and effective therapeutic targets of TNBC. Formononetin is an active ingredient with anti-tumor effects that we s...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Dong Xie, Yulang Jiang, Huan Wang, Lingyi Zhu, Shuangqin Huang, Sheng Liu, Weihong Zhang, Tian Li
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2024-09-01
Reeks:	Frontiers in Pharmacology
Onderwerpen:	triple-negative breast cancer ferroptosis Formononetin mammalian target of rapamycin complex1 sterol regulatory element-binding protein 1
Online toegang:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1441105/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!